Back to results
US 6,673,623 B1Granted
Methods and compositions that control lipid production
AssigneeNovocure GmbH
InventorEliezer Huberman
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to the use of lipogenins, proteins, e.g. human extra-cellular matrix protein 1 (ECM-1), human glia-derived nexin I alpha protein (NP-I), human tissue inhibitor of metalloproteinase-2 (TIMP-2) and human histone H2A (H2A) singly or in various combinations to control lipogenesis in a mammal.
Claims4
An assay for identifying a candidate compound which can modify the lipogenic action of a lipogenin selected from the group consisting of ECM-1, NP-I, TIMP-2 and H2A, said assay comprising;
- (a) obtaining the candidate compound;
- (b) obtaining lipogenic molecules of ECM-1, NP-I, TIMP-2 or H2A or a portion thereof;
- (c) treating target cells by contacting the treated cells wherein said cells are responsive to lipogenic induction, with the compound and the lipogenic molecules;
- and
- (d) determining if the compound interferes with the lipogenic action of the lipogenins by detecting whether fat droplets form in the target cells, and in what amounts the droplets form relative to control cells that are not treated with the candidate compound.
2 more elements
Dependencies are inferred from the claim text.